Products & ReviewLife Sciences

SARS-CoV-2 variant detection and identification

Effective genomic surveillance of SARS-CoV-2 variants begins with the right tools 

LGC Biosearch Technologies

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Average Rating 4.7

|1Scientists have reviewed this product

Ease of Use
After Sales Service
Value for Money
Write your own review

Great product with high quality results

 

Average Rating 4.7

Application Area:

Used for qualitative detection of specific SARS-CoV-2 mutations

Easy to understand the instructions. SARS-CoV-2 Variant ValuPanel™ assays gives highly specific and quality results. Highly recommended

Review Date: 11 Sept 2021 | LGC Biosearch Technologies

Emerging SARS-CoV-2 variants will require global monitoring to ensure diagnostic tests, vaccines, and other antiviral therapies remain effective. As the virus’ mutations change its transmissibility and/or severity, public health control measures can stay ahead of the curve by analysing a subset of positive COVID-19 patient samples. These genomic surveillance programs include genotyping and sequencing the mutations, which can help characterise known variants and discover novel variants.

Product Overview

Links

Products Model Information